RxDoctor Payments Data

Matthew Nadler, MD

Interventional Pain Medicine · Overland Park, KSNPI 1063414225

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,157 of the $5,140 with a category attached, or 80.9%. It is spread thinly across 30 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,261 and has fallen 80.2% since, to $646 in 2025.

$5,140in general payments, 2019–2025

Across 128 payments — averaging $40.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$906
  • Boston Scientific$828
  • Saluda Medical Americas, Inc.$494
  • Amgen$471
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$319
  • Daiichi Sankyo Inc.$237
  • plus $2K from 24 others

What the payments were for

  • Travel & lodging$78215%
  • Food & beverage$4,15781%
  • Entertainment$2014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional pain medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$80,968
Medicare patients
151
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine78$19,520
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen532$13,744
Gabapentin821$9,419
Tizanidine Hcl581$7,728
Baclofen494$7,004
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen201$5,078
Lidocaine40$3,564
Tramadol Hcl310$3,302
Pregabalin165$2,939
Fentanyl30$2,795
Methocarbamol126$2,601
Acetaminophen-CodeineAcetaminophen With Codeine123$2,228
Celecoxib121$2,195
Meloxicam375$1,658
Oxycodone Hcl61$1,424

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →